More Bioxyne Limited news
Bioxyne LimitedASX: BXN

Appendix 4D and Interim Report

Feb 22, 2022 at 1:03 AM EST · Issued by Bioxyne Limited

Filed with ASX · Feb 22, 2022 at 1:03 AM EST

On 6ix: 6ix.com/news/appendix-4d-and-interim-report-6

Bioxyne Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Bioxyne Limited on 6ix

Story so far

  • Appendix 4D and Interim ReportFeb 22, 2022
  • Explanatory Note to the 2021 Annual ReportSep 30, 2021

Earlier from Bioxyne

  • Reinstatement to Official QuotationNov 3, 2021
  • Bioxyne Not to Proceed with Proposed AcquisitionNov 3, 2021
  • Suspension from QuotationOct 28, 2021
  • Explanatory Note to the 2021 Annual ReportSep 30, 2021
  • Appendix 4C - quarterlyApr 30, 2021

Later from Bioxyne

  • Joins Asian Partner & Sells 49% of Direct Selling BusinessOct 23, 2022
  • BXN to Acquire Health & Wellness Co Breathe Life SciencesDec 18, 2022
  • BLS Extends Amazon Footprint into US and JapanJul 17, 2023
  • Retirement of DirectorNov 17, 2023
  • BXN Awarded GMP Manufacturing License for Medical CannabisFeb 4, 2024
All Bioxyne news releases↗

Follow Bioxyne into a list and get an email when it puts out news.

Follow Bioxyne
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer